EBV-Associated Polymorphic Posttransplant Lymphoproliferative Disorder Presenting as Gingival Ulcers

被引:13
|
作者
Leon, Jorge Esquiche [1 ]
Takahama Junior, Ademar
Vassallo, Jose [2 ]
Soares, Fernando Augusto [3 ]
de Almeida, Oslei Paes
Lopes, Marcio Ajudarte
机构
[1] Univ Estadual Campinas, Fac Odontol Piracicaba, Univ Campinas, Piracicaba Dent Sch,Dept Diagnost Oral, BR-13414903 Piracicaba, SP, Brazil
[2] Univ Estadual Campinas, Sch Med, CIPED, BR-13083970 Campinas, SP, Brazil
[3] Hosp AC Camargo Fund Antonio Prudente, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
oral ulcers; posttransplant; EBV; immunohistochemistry; BONE-MARROW-TRANSPLANTATION; RENAL-ALLOGRAFT RECIPIENT; B-CELL; T-CELL; LYMPHOMA; INFECTION; THERAPY; PATIENT; RISK;
D O I
10.1177/1066896909353599
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Posttransplant lymphoproliferative disorders (PTLDs) present a wide clinicopathological spectrum, varying from the usual Epstein-Barr virus (EBV)-driven infectious mononucleosis-type polyclonal proliferations to EBV-positive or EBV-negative proliferations indistinguishable from overt lymphomas that occur in immunocompetent individuals. PTLDs characteristically have a predilection for extranodal sites and association with EBV. These disorders are usually B-cell type, although T-cell and rare cases involving both T-and B-cell types have also been described. The initial treatment consists in decreasing the immnosupressive therapy, usually with favorable results. The authors report on a rare case of a 19-year-old girl, with post-renal transplantation EBV-associated polymorphic lymphoproliferative gingival ulcerated lesions. To the best of their knowledge, this is the first case described in the English-language literature of polymorphic PTLD involving both B-cell and T-cell lineages, with an unusual immunoprofile affecting the mouth. The authors warn that this condition could be easily misdiagnosed as malignant lymphoma if not properly recognized.
引用
收藏
页码:241 / 246
页数:6
相关论文
共 50 条
  • [21] EBV-associated lymphoproliferative disorders: Classification and treatment
    Carbone, Antonino
    Gloghini, Annunziata
    Dotti, Giampietro
    ONCOLOGIST, 2008, 13 (05): : 577 - 585
  • [22] EBV-Associated Lymphoproliferative Disorder and Hemophagocytic Lymphohistiocytosis in a Patient with Severe Celiac Disease
    Kinross-Wright, John Jacob
    Potu, Kalyan Chakravarthy
    Pownell, Brandy
    Lamfers, Randall
    Bleeker, Jonathan S.
    CASE REPORTS IN HEMATOLOGY, 2018, 2018
  • [23] Drug resistance mechanisms in EBV-associated multiple myeloma as posttransplantation lymphoproliferative disorder
    Sezer, O
    Hage, H
    Langelotz, C
    Pest, S
    Eucker, J
    Dietel, M
    Possinger, K
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S339 - S339
  • [24] Immunotherapy for EBV-associated lymphoproliferative disease.
    Rooney, C
    Smith, C
    Roskrow, M
    Brenner, M
    Heslop, H
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1997, 14 (04) : S18 - S18
  • [25] Polymorphic posttransplant lymphoproliferative disorder in a heart transplanted patient
    Aralica, G.
    Tomasovic-Loncaric, C.
    Manojlovic, L.
    Kristic, A.
    Manojlovic, S.
    VIRCHOWS ARCHIV, 2017, 471 : S140 - S140
  • [26] Posttransplant lymphoproliferative disorder presenting in the head and neck
    Lattyak, BV
    Rosenthal, P
    Mudge, C
    Roberts, JP
    Renze, JF
    Osorio, RW
    Emond, JC
    Lalwani, AK
    LARYNGOSCOPE, 1998, 108 (08): : 1195 - 1198
  • [27] KSHV-associated and EBV-associated Germinotropic Lymphoproliferative Disorder New Findings and Review of the Literature
    Bhavsar, Tapan
    Lee, John C.
    Perner, Yvonne
    Raffeld, Mark
    Xi, Liqiang
    Pittaluga, Stefania
    Jaffe, Elaine S.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (06) : 795 - 800
  • [30] EBV-reactivation and Posttransplant Lymphoproliferative Disorder Treated with Rituximab
    Dua, Vikas
    Yadav, Satya Prakash
    INDIAN PEDIATRICS, 2013, 50 (03) : 345 - 345